May 8, 2023 11:03 AM EDT
News Briefing

Leg­end Biotech looks to raise ad­di­tion­al $350M in stock sale; Acasti com­mits to lay­offs

Tyler Patchen

News Reporter

CAR-T out­fit Leg­end Biotech is look­ing to add more cash to its cof­fers.

On Mon­day morn­ing, Leg­end an­nounced it is sell­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times